DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Nebacumab

Nebacumab

  • 1 Therapeutic Antibodies – from Past to Future Stefan Dubel¨ and Janice M

    1 Therapeutic Antibodies – from Past to Future Stefan Dubel¨ and Janice M

  • Phage Display-Based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed Against Human Pathogens

    Phage Display-Based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed Against Human Pathogens

  • The Two Tontti Tudiul Lui Hi Ha Unit

    The Two Tontti Tudiul Lui Hi Ha Unit

  • Medicines Regulations 1984 (SR 1984/143)

    Medicines Regulations 1984 (SR 1984/143)

  • WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T

    WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T

  • Structure, Function, and Therapeutic Use of Igm Antibodies

    Structure, Function, and Therapeutic Use of Igm Antibodies

  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

    BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

  • (INN) for Biological and Biotechnological Substances

    (INN) for Biological and Biotechnological Substances

  • Orphan Drug Dummy File

    Orphan Drug Dummy File

  • Designated Indication Cumulative List of All Products That Have Received

    Designated Indication Cumulative List of All Products That Have Received

  • 1 Supplementary Materials 1 2 Data Sources 3 in Total, 60 Antibodies

    1 Supplementary Materials 1 2 Data Sources 3 in Total, 60 Antibodies

  • INN Working Document 05.179 Update 2011

    INN Working Document 05.179 Update 2011

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • (12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al

  • International Nonproprietary Names (Inn) for Biological and Biotechnological Substances

    International Nonproprietary Names (Inn) for Biological and Biotechnological Substances

  • (INN) for Biological and Biotechnological Substances

    (INN) for Biological and Biotechnological Substances

  • Developments and Challenges for Mab-Based Therapeutics

    Developments and Challenges for Mab-Based Therapeutics

  • WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT

    WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT

Top View
  • (12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
  • Orphan Drug Designations and Approvals List As of 12-02-2013 Governs January 1, 2014
  • Perspectives
  • Orphan Drug Designation List
  • International Nonproprietary Names (INN) for Biological and Biotechnological Substances
  • © Copyright 2018 Dennis Ryan Goulet
  • ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
  • Update on Monoclonal Antibody Therapy in the Gram-Negative Sepsis Syndrome
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • Copyrighted Material
  • Fig. 2 O W O 2012/149282 A2 1Inn Iiiiiii 1Mil I Mil Il I 1Ill I Mil I Il I I Mill Mi I I
  • LIST of ORPHAN PRODUCTS DESIGNATIONS and APPROVALS Throughdecember 31,1999 NAME SPONSOR &
  • Engineered Fc Regions for Site-Specific Conjugation
  • Guidelines for ATC Classification and DDD Assignment 2021
  • Guidelines for ATC Classification and DDD Assignment 2011
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0293.086 A1 MESSMER Et Al
  • WO 2012/109624 A2 16 August 2012 (16.08.2012) P O P C T
  • Orphan Drug Designations and Approvals List As of 12‐01‐2014


© 2024 Docslib.org    Feedback